Medicine and Dentistry
Liver Fibrosis
100%
Fibrosis
89%
Alcohol-Related Liver Disease
86%
Liver Cirrhosis
65%
Nonalcoholic Fatty Liver
63%
Fatty Liver
58%
Steatosis
58%
Shear Wave Elastography
42%
Liver Disease
39%
Elastography
38%
Alcohol Liver Disease
38%
Diagnostic Accuracy
37%
Biological Marker
36%
Gut
35%
Patient-Data
35%
Meta-Analysis
35%
Transient Elastography
31%
Body Mass Index
30%
Liver Biopsy
29%
Diagnosis
25%
FibroTest
23%
Disease
23%
Health Care Cost
21%
Portal Hypertension
21%
Alcohol Liver Cirrhosis
20%
Chronic Liver Disease
19%
Alanine Aminotransferase
17%
Feces
17%
Metabolite
17%
Detoxication
17%
Aspartic Acid
17%
Cost-Effectiveness Analysis
17%
Ultra Performance Liquid Chromatography
17%
Western Diet
17%
Alcohol
17%
Cathepsin D
17%
Metabolic Dysfunction-Associated Steatotic Liver Disease
17%
Prevalence
16%
Biopsy Technique
15%
Upregulation
13%
Patient Referral
11%
Quality Adjusted Life Year
11%
Primary Health Care
11%
Secondary Care
10%
Model for End-Stage Liver Disease
10%
Focused Ion Beam
9%
Risk Stratification
9%
Triacylglycerol
8%
Immunohistochemistry
8%
Gene Expression
8%
Gut Microbiome
7%
Microbiome
7%
Tamsulosin
7%
Disease Exacerbation
7%
Systems Medicine
7%
Model For End Stage Liver Disease Score
7%
Disease Course
7%
Diseases
7%
Population
6%
Diabetes
5%
Hepatitis Virus
5%
Varices
5%
Aspartate Aminotransferase
5%
Biochemistry, Genetics and Molecular Biology
Rigidity
73%
Patient Coding
53%
Body Mass
41%
Blood Plasma
41%
Serology
17%
Prevalence
17%
Proteomics
17%
Genetic Risk
17%
Upregulation
17%
Cell Kinetics
17%
Insulin Resistance
17%
Hepatitis C Virus
17%
Argonaute
17%
Cell Division
17%
Cathepsin D
17%
Sphingomyelin
17%
Sphingolipid
17%
Triglyceride
14%
PNPLA3
14%
Lipid
12%
Gene Expression Level
11%
Quality Adjusted Life Year
11%
Mass Spectrometry
9%
Venous Pressure
8%
Pressure Gradient
8%
Hepatitis Virus
7%
Focused Ion Beam
6%
Cholesterol Blood Level
5%
Fatty Acid Synthesis
5%
Gene Expression Profiling
5%
Drug Screening
5%
Animal Model
5%
Western Blotting
5%
Genetic Susceptibility
5%
Mendelian Randomization
5%
Pharmacology, Toxicology and Pharmaceutical Science
Fibrosis
64%
Ethanol
49%
Liver Fibrosis
44%
Liver Disease
40%
Nonalcoholic Fatty Liver
40%
Steatosis
31%
Fatty Liver
27%
Inflammation
25%
Disease
21%
Prevalence
18%
Ultra High Performance Liquid Chromatography
17%
Injury
17%
Carbon Tetrachloride
16%
Triacylglycerol
8%
Drug Screening
6%
Amino Acid
5%
Bile Acid
5%
Metabolic Disorder
5%
Virus Hepatitis
5%